Narrow search
Showing 1 - 10 of 3,093
Cover Image
Implementing personalized medicine with asymmetric information on prevalence rates
Antoñanzas Villar, Fernando; Juárez-Castelló, Carmelo A. - In: Health economics review 6 (2016) 35, pp. 1-8
Although personalized medicine is becoming the new paradigm to manage some diseases, the economics of personalized medicine have only focused on assessing the efficiency of specific treatments, lacking a theoretical framework analyzing the interactions between pharmaceutical firms and healthcare...
Persistent link: https://www.econbiz.de/10011586604
Cover Image
External Reference Pricing and the Choice of Country Baskets and Pricing Rules
Birg, Laura - 2016
This paper models different external reference pricing schemes -- a price cap based on the drug price in one or two … countries and on the minimum or average drug price -- in a three-country framework. It studies the choice of external reference … under the minimum price-rule or under the average price-rule. External reference pricing increases the drug price and …
Persistent link: https://www.econbiz.de/10012998253
Cover Image
The Price of Cost-Effectiveness Thresholds
Brekke, Kurt Richard; Dalen, Dag Morten; Straume, Odd Rune - 2023
deterrence in which the price reduction by the incumbent necessary to deter entry outweighs the health loss to patients not …
Persistent link: https://www.econbiz.de/10014256577
Cover Image
Hospital competition and quality with regulated prices
Brekke, Kurt R.; Siciliani, Luigi; Straume, Odd Rune - 2009
We analyse the effect of competition on quality in hospital markets with regulated prices, considering both the effect of (i) introducing competition (monopoly versus competition) and (ii) increasing competition through lower transportation costs (increased substitutability) or a higher number...
Persistent link: https://www.econbiz.de/10003850156
Cover Image
A simple model of health insurance competition
Kemnitz, Alexander - 2010
This paper investigates competition between health insurance companies under different financing regulations. We consider two alternatives advanced in recent German health care reform discussions: competition by contribution rates (health contributions) and by fees (health premia). We find that...
Persistent link: https://www.econbiz.de/10008698408
Cover Image
Monopolistic competition and costs in the health care sector
Kumpmann, Ingmar - 2009
selectively with health care providers as long as there are no price differences between physicians. A monopolistic health insurer …
Persistent link: https://www.econbiz.de/10003928694
Cover Image
Why the linear utility function is a risky choice in discrete-choice experiments
Sennhauser, Michèle - 2010
This article assesses how the form of the utility function in discrete-choice experiments (DCEs) affects estimates of willingness-to-pay (WTP). The utility function is usually assumed to be linear in its attributes. Non-linearities, in the guise of interactions and higher-order terms, are...
Persistent link: https://www.econbiz.de/10008702182
Cover Image
P4P, reputation and the reduction of costly overprovision
Kairies-Schwarz, Nadja - 2012
We investigate the effect of reputational motivation on output in a scenario of overprovision of medical treatment. We assume that physicians differ in their degree of altruism, enjoy being perceived as good but dislike being perceived as greedy. We show that better reputational motivation...
Persistent link: https://www.econbiz.de/10009580168
Cover Image
A simple model of health insurance competition
Kemnitz, Alexander - 2010
This paper investigates competition between health insurance companies under different financing regulations. We consider two alternatives advanced in recent German health care reform discussions: competition by contribution rates (health contributions) and by fees (health premia). We find that...
Persistent link: https://www.econbiz.de/10009229026
Cover Image
Pharmaceutical regulation, mandatory substitution, and generic competition
Birg, Laura - 2015
This paper studies the effect of two regulatory instruments - a price cap and a reference price system - a mandatory … n differentiated generic versions. The price cap reduces only the brand-name price, the reference price system reduces … the brand-name price and generic prices. Both regulatory instruments reduce the generic market share and the number of …
Persistent link: https://www.econbiz.de/10010510801